Imject
Maleimide Activated BSA Kit (Pierce)
Includes: Imject Maleimide Activated BSA
5
x 2 mg
All
Conjugation and Purification Buffers
Prepacked
Gel Filtration Columns
5
x 5 ml
See
the instructions from the Pierce kit.
A. Conjugation Procedure
1. Reconstitute one vial
of the maleimide-activated protein by adding 200 ul of ultrapure water to make
a 10 mg/ml solution.
Note: Vortex mixing or heating will cause the protein to
precipitate.
2. Dissolve the
sulfhydryl-containing hapten in a volume of Conjugation Buffer equal to 1.0-2.5
times the volume of reconstituted activated protein. For example dissolve 2 mg
of peptide in 200-500 ul of buffer and add it to the reconstituted protein.
Alternatively, if the peptide is freely soluble it may be added as a solid to
the protein solution.
Note: For haptens with limited solubility, DMSO may be used
for solubilization. Use approximately 30% DMSO in the final conjugation
solution or the carrier protein may irreversibly denature.
3. Immediately mix the peptide
and activated protein and react for 2 hours at room temperature.
4. Purify the conjugate by
desalting or dialysis to remove EDTA and sodium azide.
B. Conjugate
Purification by Desalting
Use either desalting or
dialysis to remove EDTA and sodium azide. If DMSO was used in the conjugation,
add DMSO to the Purification Buffer Salts for desalting to prevent
precipitation in the column; dialysis is not compatible with DMSO.
Desalting or dialysis will
not separate non-conjugated protein; however, a large excess of hapten is used
in this protocol, making it unlikely that non-conjugated carrier exists in
significant quantity.
If the conjugate is to be
used for injection within one week, PBS may be used for purification. If the
conjugate will be frozen, use Purification Buffer Salts for purification, which
will preserve the product during freeze-thaw cycles. If a precipitate formed
during conjugation, centrifuge the precipitated material, collect the
supernatant and save the precipitate. Purify only the supernatant. Combine the
purified conjugate to the precipitate.
This is what I do.
Use the columns provided with the kit.
1. For desalting, dissolve
the contents of one bottle of Purification Buffer Salts by adding 60 ml
degassed, ultrapure water
to the bottle. Store
excess buffer at 4C.
2. Sequentially remove the
top and bottom caps from a desalting column and allow the storage solution to
drain. Use one
desalting column for each
0.5 ml of sample.
3. Wash column with 3-5
column volumes (i.e., 15-25 ml) of Purification Buffer.
4. Apply 0.5 ml of the
hapten-carrier mixture directly to the center of the column disc. Add 8-10
aliquots of 0.5 ml of
Purification Buffer and
collect each fraction in a separate tube.
5. Measure absorbance at
280 nm to locate fractions containing the conjugate. The hapten-carrier
conjugate will be in the first absorbance peak detected. Pool all fractions
that contain acceptable levels of conjugate.
6. After the
conjugate-containing fractions have emerged, the non-conjugated hapten can be
recovered by continuing to add
buffer to the column and
collecting additional fractions.
7. If the immunogen is to
be stored for more than a few days, sterile filter the conjugate fractions and
store in a sterile
container at 4¡C or -20C.
See Appendix B for immunization suggestions.
Note: To purify antibodies specific to the peptide, prepare
an affinity column by immobilizing the peptide through the same functional
group used to prepare the immunogen (see Appendix C).
C. Checking
The conjugation can be
checked by running the unconjugated BSA, and the AcBSA conjugated to the
peptides. A band shift in the AcBSA lane is indicative of total conjugation.